117 episodes

"Talks at GS" convenes leading thinkers to share insights and ideas shaping the world.

Talks at GS Goldman Sachs

    • Business

"Talks at GS" convenes leading thinkers to share insights and ideas shaping the world.

    Jonathan Karl, Chief White House Correspondent for ABC News

    Jonathan Karl, Chief White House Correspondent for ABC News

    In this episode, journalist Jonathan Karl discusses covering the Trump administration during the coronavirus crisis as well as his insights from covering President Trump for decades, as described in his new book, Front Row at the Trump Show. The interview is moderated by Goldman Sachs' Jake Siewert.

    The interview was recorded on April 1, 2020.


    This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

    Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

    • 28 min
    The CARES Act and its Impact on the US Economic Outlook

    The CARES Act and its Impact on the US Economic Outlook

    In this episode of Talks at GS, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the economic implications of the recently passed Coronavirus Aid, Relief, and Economic Security Act with a group of leading economic experts. This conversation was recorded as a phone call on March 31, 2020.
     
    Click below to view materials referenced during the podcast:
    https://www.goldmansachs.com/insights/talks-at-gs/04-01-20-cares-act-impact-on-us-economic-outlook-f/report.pdf

    Participants include:
    Alec Phillips, Chief US Political Economist, Goldman Sachs Research
    Jan Hatzius, Chief Economist, Goldman Sachs Research
    William G. Gale, Arjay and Frances Miller Chair in Federal Economic Policy and senior fellow, Brookings Institution


    This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

    Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

    • 52 min
    US Senators Marco Rubio and Ben Cardin

    US Senators Marco Rubio and Ben Cardin

    In this episode of Talks at GS, US Senators Marco Rubio and Ben Cardin discuss the federal policy response to the coronavirus pandemic and how the recently passed Coronavirus Aid, Relief, and Economic Security Act impacts small businesses. The conversation is moderated by Goldman Sachs Chairman and CEO David Solomon and recorded as a phone call on March 30, 2020.

    This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

    Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

    • 40 min
    An Update on the Economic and Public Health Implications of Coronavirus for Europe

    An Update on the Economic and Public Health Implications of Coronavirus for Europe

    In this episode of Talks at GS, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses the economic and public health implications of coronavirus for Europe with a number of leading health and economic experts. This conversation was recorded as a phone call on March 26, 2020.
    Click below to view materials referenced during the podcast:
    https://www.goldmansachs.com/insights/talks-at-gs/03-26-20-update-coronavirus-europe-f/report.pdf

    Participants include:
    Dr. David Heymann, MD, Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine
    Sven Jari Stehn, Managing Director, Goldman Sachs Research
    Silvia Ardagna, Managing Director, Goldman Sachs Investment Strategy Group
    Peter Oppenheimer, Managing Director, Goldman Sachs Research


    This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

    Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

    • 57 min
    A Coronavirus Update with Leading Health Experts and Business Leaders

    A Coronavirus Update with Leading Health Experts and Business Leaders

    In this episode of Talks at GS, Goldman Sachs’ Sharmin Mossavar-Rahmani discusses coronavirus testing, hospital readiness and the search for a therapy and vaccine with a number of leading health experts and business leaders.
    Click below to view materials referenced during the podcast:
    https://www.goldmansachs.com/insights/talks-at-gs/sharmin-mossavar-rahmani-f/deck.pdf
     
    Participants include:
    Dr. Thomas Schinecker, CEO of Roche Diagnostics
    Steve Rusckowski, CEO of Quest Diagnostics
    Dr. Leonard Schleifer, MD, CEO of Regeneron
    Stéphane Bancel, CEO of Moderna
    Pablo Tebas, MD, University of Pennsylvania and National Institute of Health Supported Investigator
    Peter Slavin, MD, President, Massachusetts General Hospital
    Dr. Barry Bloom, Harvard T.H. Chan School of Public Health

    This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

    Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

    • 1 hr 21 min
    Dr. Michael Mina of the Harvard T.H. Chan School of Public Health

    Dr. Michael Mina of the Harvard T.H. Chan School of Public Health

    In this episode of Talks at GS, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines. This conversation was recorded as a phone call between Dr. Mina and Salveen Richter and Terence Flynn of Goldman Sachs Research on March 17, 2020.


    This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.

    Copyright 2020 Goldman Sachs & Co. LLC. All rights reserved.

    • 1 hr 4 min

Top Podcasts In Business

Listeners Also Subscribed To